日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomes

帕博利珠单抗治疗微卫星稳定型、肿瘤突变负荷高转移性结直肠癌的疗效:基因组特征和临床结果

Yamaguchi, K; Tsuchihashi, K; Ueno, S; Uehara, K; Taguchi, R; Ito, M; Isobe, T; Imajima, T; Kitazono, T; Tanoue, K; Ohmura, H; Akashi, K; Baba, E

Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2)

纳米脂质体伊立替康联合氟尿嘧啶和亚叶酸治疗不可切除或复发性胰腺癌患者:一项多中心观察性研究(NAPOLEON-2)

Shirakawa, T; Shimokawa, M; Otsuka, T; Shinohara, Y; Toyodome, K; Kusano, W; Nakazawa, J; Kodama, T; Kawahira, M; Shimokawa, H; Koike, T; Koga, F; Yunotani, S; Nakashita, S; Oza, N; Noge, S; Murayama, K; Oda, H; Mitsui, N; Kawasaki, R; Morikita, T; Takeshita, S; Arima, S; Shibata, R; Kakihara, A; Yoshihiro, T; Imajima, T; Yamaga, S; Arita, S; Kawaguchi, Y; Nishikawa, K; Inagaki, T; Otsu, S; Taguchi, H; Jikuya, K; Terada, T; Sakai, T; Ueda, Y; Sakae, T; Sawase, H; Kawahira, M; Nio, K; Araki, N; Sakai, K; Ide, Y; Shibuki, T; Miwa, K; Kubotsu, Y; Hosokawa, A; Komori, A; Honda, T; Tsuneyoshi, K; Fujita, T; Mizuta, T; Mitsugi, K

A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer

一项多中心回顾性观察性 NAPOLEON2 研究,旨在评估纳米脂质体伊立替康联合氟尿嘧啶和亚叶酸治疗不可切除胰腺癌患者的疗效。

Kodama, Tomoko; Imajima, Takashi; Shimokawa, Mototsugu; Otsuka, Taiga; Kawahira, Masahiro; Nakazawa, Junichi; Hori, Takeshi; Shibuki, Taro; Arima, Shiho; Ido, Akio; Miwa, Keisuke; Okabe, Yoshinobu; Koga, Futa; Ueda, Yujiro; Kubotsu, Yoshihito; Shimokawa, Hozumi; Takeshita, Shigeyuki; Nishikawa, Kazuo; Komori, Azusa; Otsu, Satoshi; Hosokawa, Ayumu; Sakai, Tatsunori; Sakai, Kenji; Oda, Hisanobu; Kawahira, Machiko; Arita, Shuji; Honda, Takuya; Taguchi, Hiroki; Tsuneyoshi, Kengo; Kawaguchi, Yasunori; Fujita, Toshihiro; Sakae, Takahiro; Shirakawa, Tsuyoshi; Mizuta, Toshihiko; Mitsugi, Kenji

KS-cSCC-1 and KS-cSCC-2: two novel cutaneous squamous cell carcinoma cell lines established from Japanese patients

KS-cSCC-1 和 KS-cSCC-2:从日本患者建立的两种新型皮肤鳞状细胞癌细胞系

Takamichi Ito, Yuka Tanaka, Yumiko Kaku-Ito, Keiko Tanegashima, Mao Imajima, Toshio Ichiki, Takeshi Nakahara

Nutritional Status Is Associated With Physical Improvement of Palliative Cancer Patients During Cancer Rehabilitation

营养状况与癌症康复期间姑息治疗癌症患者的身体改善相关

Imajima, Takashi; Shirakawa, Tsuyoshi; Ohtsu, Yasuyuki; Uchihashi, Hitomi; Otsuka, Taiga; Akashi, Koichi; Baba, Eishi; Mitsugi, Kenji

Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer

抑制胰岛素样生长因子-1受体可增强艾立布林诱导的结直肠癌DNA损伤

Yoshihiro, Tomoyasu; Ariyama, Hiroshi; Yamaguchi, Kyoko; Imajima, Takashi; Yamaga, Satoru; Tsuchihashi, Kenji; Isobe, Taichi; Kusaba, Hitoshi; Akashi, Koichi; Baba, Eishi

Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin

对于存在多柔比星禁忌症的软组织肉瘤患者,艾立布林可作为一线治疗方案。

Tsuchihashi, Kenji; Kusaba, Hitoshi; Yoshihiro, Tomoyasu; Fujiwara, Toshifumi; Setsu, Nokitaka; Endo, Makoto; Matsumoto, Yoshihiro; Imajima, Takashi; Shinohara, Yudai; Ito, Mamoru; Yamaga, Satoru; Tanoue, Kenro; Arimizu, Kohei; Ohmura, Hirofumi; Hanamura, Fumiyasu; Yamaguchi, Kyoko; Isobe, Taichi; Ariyama, Hiroshi; Nakashima, Yasuharu; Akashi, Koichi; Baba, Eishi

The CD133+CD44+ precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma

CD133+CD44+ 癌前卵圆细胞亚群是肝细胞癌的治疗靶点

Yun-Wen Zheng, Tomonori Tsuchida, Taiki Shimao, Bin Li, Takanori Takebe, Ran-Ran Zhang, Yu Sakurai, Yasuharu Ueno, Keisuke Sekine, Naoto Ishibashi, Makiko Imajima, Takuji Tanaka, Hideki Taniguchi